FindTrial
Sign In

Prognosis of Cancer through Ayurvedic urine examination

Evaluation of Tailabindu Pareeksha as an alternate method for conventional method in context of disease prognosis w.s.r to malignancy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029380
Enrollment
50
Registered
2020-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

IPGT and RA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group A Patients of any type of malignancy irrespective of age gender occupation religion Histo-pathologically confirmed and clinically stage II cases of Malignancy and advised for Radiation or chemotherapy for further management Group B Healthy volunteers as Control group Individual between 20- 40 years of age

Exclusion criteria

Exclusion criteria: Group A Malignancy patients who are terminally ill and on palliative medicine only Group B Age below 20 and above 40 years

Design outcomes

Primary

MeasureTime frame
Variation in shapes and direction of flow of Taila binduTimepoint: Immediately after examination—

Secondary

MeasureTime frame
To predict the prognosis of the diseaseTimepoint: After the follow up period—

Countries

India

Contacts

Public ContactDr V J Shukla

I P G T and R A JAMNAGAR

darshnapandya73@gmail.com9099011095

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026